Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, according to findings from the recently completed, international, phase-III POLO (Pancreas ...
Jun 3, 2019
0
3
Crizotinib was the first drug licensed to treat ALK-positive non-small cell lung cancer (ALK+ NSCLC). Since then, a range of next-generation ALK-inhibitors including ceritinib, alectinib, and brigatinib have earned FDA approval ...
May 31, 2019
0
1
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from ...
May 17, 2019
0
3
(HealthDay)—A low-fat dietary intervention is associated with reductions in deaths after breast cancer and deaths from breast cancer among postmenopausal women after long-term follow-up, according to a study scheduled to ...
May 16, 2019
0
2
Small spots on CT scans of the lungs of children with muscle cancer do not have an adverse effect on survival, according to an international research team in the Journal for Clinical Oncology. This conclusion has direct consequences ...
Feb 15, 2019
0
9
The first report from a phase II, multi-center clinical trial indicates that a newer, more aggressive form of radiation therapy—stereotactic radiation—can extend long-term survival for some patients with stage-IV cancers ...
Jan 31, 2019
0
0
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...
Nov 16, 2018
0
8
(HealthDay)—In addition to fear of pain and suffering, Americans worry about cancer-related expenses, according to the results of the American Society of Clinical Oncology (ASCO) 2018 National Cancer Opinion Survey.
Nov 6, 2018
0
0
While most oncologists would agree that exercise is important for people with cancer, generic guidelines for this population do not address the high need for personalized exercises.
Oct 5, 2018
0
3
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...
Aug 30, 2018
0
3
